【細胞淋巴瘤】Lantern Pharma在美國血液學會展示治療細胞淋巴瘤 (MCL)候選藥物LP-284新臨床前數據

 原文: Lantern Pharma Announces Positive New Data for its Drug Candidate LP-284 for Mantle Cell Lymphoma (MCL) at the American Society of Hematology (ASH) 2022 Annual Meeting

出處: Businesswire

#科研 # 2649